Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rafiuddin, Asfi
NCT06453213: Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy	Recruiting	4	90	US	Cenobamate	SK Life Science, Inc.	Focal Onset Seizure	05/27	07/27
TrustTSC, NCT05323734 / 2021-003441-38: Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy	Completed	3	128	Europe, Canada, US, RoW	Ganaxalone, Placebo	Marinus Pharmaceuticals, Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals, Inc.	Tuberous Sclerosis Complex	09/24	10/24
NCT05473442: Study of EQU-001 for Uncontrolled Focal Onset Seizures	Terminated	2	27	US, RoW	EQU-001, Matching Placebo	Equilibre Biopharmaceuticals B.V.	Focal Onset Seizures	07/23	07/23
GenTLE, NCT06063850: AMT-260 Gene Therapy Study in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy	Recruiting	1/2	12	US	AAV9-hSyn1-miGRIK2, AMT-260	UniQure Biopharma B.V.	Mesial Temporal Lobe Epilepsy	11/26	06/27